Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Aurora Cannabis Inc. (T:ACB)

Business Focus: Alternative Medicine

Sector:  Healthcare Industry:  Pharmaceuticals
 
Company Contact
Address: 2207 90B Street Sw
LEDUC AB T6X 1V8
Tel: N/A
Website: https://www.auroramj.com
IR: See website
Key People
Miguel Martin
Chief Executive Officer, Director
Simona King
Chief Financial Officer
Nathalie Clark
Executive Vice President, General Counsel, Company Secretary
Lori Schick
Executive Vice President - Human Resources
Andre Jerome
Executive Vice President - Global Business Development
Alex Miller
Executive Vice President - Operations and Supply Chain
Business Overview
Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company's segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Bradford Ontario, Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.
Financial Overview
For the nine months ended 31 December 2023, Aurora Cannabis Inc revenues increased 83% to C$202.9M. Net loss before extraordinary items decreased 63% to C$43.1M. Revenues reflect Cannabis segment increase of 90% to C$148.5M, Canada (Country) segment increase of 96% to C$172M, European Union (Region) segment increase of 83% to C$30.2M. Lower net loss reflects Unrealized gain on changes in fair value increase from C$27.4M to C$86.1M (income).
Employees: 1,130 as of Mar 31, 2023
Reporting Currency: Canadian Dollars
Enterprise value: $343.81M as of Dec 31, 2023
Annual revenue (TTM): $266.97M as of Dec 31, 2023
EBITDA (TTM): -$134.82M as of Dec 31, 2023
Net annual income (TTM): -$125.07M as of Dec 31, 2023
Free cash flow (TTM): -$86.25M as of Dec 31, 2023
Net Debt Last Fiscal Year: N/A
Shares outstanding: 54,539,376 as of Feb 21, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization